Brain [F-18] FDG PET for clinical dementia workup: differential diagnosis of Alzheimer's disease and other types of dementing disorders
PET imaging with [F-18] FDG has been used extensively for research and clinical
applications in dementia. In the brain,[F-18] FDG accumulates around synapses and …
applications in dementia. In the brain,[F-18] FDG accumulates around synapses and …
[HTML][HTML] Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia
Purpose There are no comprehensive guidelines for the use of FDG PET in the following
three clinical scenarios:(1) diagnostic work-up of patients with idiopathic Parkinson's …
three clinical scenarios:(1) diagnostic work-up of patients with idiopathic Parkinson's …
18F-FDG PET imaging in neurodegenerative dementing disorders: insights into subtype classification, emerging disease categories, and mixed dementia with …
S Minoshima, D Cross, T Thientunyakit… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Since the invention of 18 F-FDG as a neurochemical tracer in the 1970s, 18 F-FDG PET has
been used extensively for dementia research and clinical applications. FDG, a glucose …
been used extensively for dementia research and clinical applications. FDG, a glucose …
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F‐fluorodeoxyglucose positron emission …
Background and purpose Recommendations for using fluorodeoxyglucose positron
emission tomography (FDG‐PET) to support the diagnosis of dementing neurodegenerative …
emission tomography (FDG‐PET) to support the diagnosis of dementing neurodegenerative …
Molecular imaging in dementia: Past, present, and future
R Laforce Jr, JP Soucy, L Sellami… - Alzheimer's & …, 2018 - Elsevier
Molecular imaging techniques using 18 F-fluorodeoxyglucose, amyloid tracers, and, more
recently, tau ligands have taken dementia research by storm and undoubtedly improved our …
recently, tau ligands have taken dementia research by storm and undoubtedly improved our …
FDG‐PET patterns predict amyloid deposition and clinical profile in Corticobasal syndrome
Background Corticobasal syndrome (CBS) is an atypical parkinsonian syndrome related to
multiple underlying pathologies. Objective To investigate if individual brain [18F] …
multiple underlying pathologies. Objective To investigate if individual brain [18F] …
[HTML][HTML] The role of single-subject brain metabolic patterns in the early differential diagnosis of primary progressive aphasias and in prediction of progression to …
Abstract Background and Objective: Primary progressive aphasia (PPA) is a clinical
syndrome due to different neurodegenerative conditions in which an accurate early …
syndrome due to different neurodegenerative conditions in which an accurate early …
Brain metabolic signatures across the Alzheimer's disease spectrum
A Sala, C Caprioglio, R Santangelo, EG Vanoli… - European journal of …, 2020 - Springer
Purpose Given the challenges posed by the clinical diagnosis of atypical Alzheimer's
disease (AD) variants and the limited imaging evidence available in the prodromal phases …
disease (AD) variants and the limited imaging evidence available in the prodromal phases …
[HTML][HTML] Atrophy, hypometabolism and implication regarding pathology in late-life major depression with suspected non-alzheimer pathophysiology (SNAP)
KY Wu, KJ Lin, CH Chen, CY Liu, YM Wu, TC Yen… - biomedical …, 2023 - Elsevier
Background A substantial proportion of individuals with late-life major depression could be
classified as having a suspected non-Alzheimer disease pathophysiology (SNAP), as …
classified as having a suspected non-Alzheimer disease pathophysiology (SNAP), as …
[HTML][HTML] Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia
F Bouwman, S Orini, F Gandolfo, D Altomare… - European journal of …, 2018 - Springer
Purpose A joint effort of the European Association of Nuclear Medicine (EANM) and the
European Academy of Neurology (EAN) aims at clinical guidance for the use of FDG-PET in …
European Academy of Neurology (EAN) aims at clinical guidance for the use of FDG-PET in …